{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T02:00:31Z","timestamp":1785636031199,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["388159768"],"award-info":[{"award-number":["388159768"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BE 1822"],"award-info":[{"award-number":["BE 1822"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008131","name":"Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012628","name":"The Japan Epilepsy Research Foundation","doi-asserted-by":"publisher","award":["TENKAN 20101"],"award-info":[{"award-number":["TENKAN 20101"]}],"id":[{"id":"10.13039\/501100012628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005123","name":"Japanese Society of Nephrology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005123","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178147","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T09:15:31Z","timestamp":1757754931000},"page":"178147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effects of dibenzazepine compounds on Nav1.2 channels and neuronal network activity: A systematic comparison"],"prefix":"10.1016","volume":"1006","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0859-7046","authenticated-orcid":false,"given":"Kunihiko","family":"Araki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin Felix","family":"Schwering-Sohnrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griselda","family":"Marku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Schoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoralf","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178147_bib1","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/0091270005279364","article-title":"Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects","volume":"45","author":"Almeida","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178147_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.nurt.2006.10.005","article-title":"Eslicarbazepine acetate (BIA 2-093)","volume":"4","author":"Almeida","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2025.178147_bib3","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1172\/JCI124481","article-title":"TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets","volume":"129","author":"Araki","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178147_bib4","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1523\/JNEUROSCI.0640-18.2018","article-title":"Polyamine modulation of anticonvulsant drug response: a potential mechanism contributing to pharmacoresistance in chronic epilepsy","volume":"38","author":"Beckonert","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178147_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.seizure.2020.10.018","article-title":"Current role of carbamazepine and oxcarbazepine in the management of epilepsy","volume":"83","author":"Beydoun","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.ejphar.2025.178147_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev-pharmtox-010818-021757","article-title":"Structure and pharmacology of voltage-gated sodium and calcium channels","volume":"60","author":"Catterall","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178147_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuron.2006.01.009","article-title":"Neuromodulation of Na+ channel slow inactivation via cAMP-dependent protein kinase and protein kinase C","volume":"49","author":"Chen","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2025.178147_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/brain\/awu339","article-title":"Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug","volume":"138","author":"Doeser","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2025.178147_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.107.039867","article-title":"The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels","volume":"73","author":"Errington","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178147_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eplepsyres.2013.08.013","article-title":"Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models","volume":"107","author":"Fortuna","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2025.178147_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40268-017-0197-5","article-title":"Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures","volume":"17","author":"Galiana","year":"2017","journal-title":"Drugs R D"},{"key":"10.1016\/j.ejphar.2025.178147_bib11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0959-4388(03)00065-5","article-title":"Mechanisms of sodium channel inactivation","volume":"13","author":"Goldin","year":"2003","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.178147_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2014.09.008","article-title":"Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide","volume":"89","author":"Hebeisen","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.178147_bib13","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/epi.14504","article-title":"Effects of eslicarbazepine on slow inactivation processes of sodium channels in dentate gyrus granule cells","volume":"59","author":"Holtkamp","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.178147_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/epi.13602","article-title":"Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na(+) channel inactivation","volume":"58","author":"Holtkamp","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.178147_bib15","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nn.2359","article-title":"Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation","volume":"12","author":"Hu","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178147_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuropharm.2017.09.018","article-title":"Voltage-gated sodium channel beta subunits: the power outside the pore in brain development and disease","volume":"132","author":"Hull","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.178147_bib17","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/cts.13344","article-title":"The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and white subjects","volume":"15","author":"Hwang","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ejphar.2025.178147_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/mol.116.106401","article-title":"Lacosamide inhibition of Nav1.7 voltage-gated sodium channels: slow binding to fast-inactivated states","volume":"91","author":"Jo","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178147_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000818","article-title":"Fast- or slow-inactivated state preference of Na+ channel inhibitors: a simulation and experimental study","volume":"6","author":"Karoly","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejphar.2025.178147_bib20","article-title":"Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures","volume":"CD006453","author":"Koch","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2025.178147_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40120-018-0111-2","article-title":"Dibenzazepine agents in epilepsy: how does eslicarbazepine acetate differ?","volume":"7","author":"Lawthom","year":"2018","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.ejphar.2025.178147_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.555047","article-title":"Inhibitory effect of eslicarbazepine acetate and S-Licarbazepine on Na(v)1.5 channels","volume":"11","author":"Leslie","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178147_bib23","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/brain\/awac455","article-title":"Targeting aberrant dendritic integration to treat cognitive comorbidities of epilepsy","volume":"146","author":"Masala","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2025.178147_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-5793(03)00912-8","article-title":"Negatively charged residues adjacent to IFM motif in the DIII-DIV linker of hNa(V)1.4 differentially affect slow inactivation","volume":"552","author":"McCollum","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2025.178147_bib25","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1074\/jbc.273.7.3954","article-title":"Molecular determinants of Na+ channel function in the extracellular domain of the beta1 subunit","volume":"273","author":"McCormick","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178147_bib26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jnr.23136","article-title":"Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation","volume":"91","author":"Niespodziany","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2025.178147_bib27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s42003-018-0099-2","article-title":"Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice","volume":"1","author":"Ogiwara","year":"2018","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejphar.2025.178147_bib28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev-physiol-021014-071846","article-title":"Sodium channel beta subunits: emerging targets in channelopathies","volume":"77","author":"O'Malley","year":"2015","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2025.178147_bib29","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/bph.12534","article-title":"Properties of human brain sodium channel alpha-subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine","volume":"171","author":"Qiao","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178147_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awh682","article-title":"Molecular and cellular mechanisms of pharmacoresistance in epilepsy","volume":"129","author":"Remy","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2025.178147_bib31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ana.10473","article-title":"A novel mechanism underlying drug resistance in chronic epilepsy","volume":"53","author":"Remy","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2025.178147_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.yebeh.2004.07.004","article-title":"What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?","volume":"5","author":"Schmidt","year":"2004","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2025.178147_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109483","article-title":"Paradoxical hyperexcitability from Na(V)1.2 sodium channel loss in neocortical pyramidal cells","volume":"36","author":"Spratt","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2025.178147_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neuron.2019.05.037","article-title":"The autism-associated gene Scn2a contributes to dendritic excitability and synaptic function in the prefrontal cortex","volume":"103","author":"Spratt","year":"2019","journal-title":"Neuron"},{"issue":"Suppl. 5","key":"10.1016\/j.ejphar.2025.178147_bib35","first-page":"S37","article-title":"Oxcarbazepine","volume":"40","author":"Tecoma","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.178147_bib43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/epi.13993","article-title":"Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study","volume":"59","author":"Trinka","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.178147_bib36","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1528-1167.2012.03675.x","article-title":"Loss of beta1 accessory Na+ channel subunits causes failure of carbamazepine, but not of lacosamide, in blocking high-frequency firing via differential effects on persistent Na+ currents","volume":"53","author":"Uebachs","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2025.178147_bib37","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1523\/JNEUROSCI.1534-10.2010","article-title":"Efficacy loss of the anticonvulsant carbamazepine in mice lacking sodium channel beta subunits via paradoxical effects on persistent sodium currents","volume":"30","author":"Uebachs","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178147_bib38","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0006-3495(99)76987-0","article-title":"Structural determinants of slow inactivation in human cardiac and skeletal muscle sodium channels","volume":"77","author":"Vilin","year":"1999","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2025.178147_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1385\/CBB:35:2:171","article-title":"Slow inactivation in voltage-gated sodium channels: molecular substrates and contributions to channelopathies","volume":"35","author":"Vilin","year":"2001","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2025.178147_bib40","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/epi.14563","article-title":"Recurrent epileptiform discharges in the medial entorhinal cortex of kainate-treated rats are differentially sensitive to antiseizure drugs","volume":"59","author":"West","year":"2018","journal-title":"Epilepsia"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992500901X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992500901X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:38:57Z","timestamp":1780202337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992500901X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":42,"alternative-id":["S001429992500901X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178147","relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.172708657.76144438\/v1","asserted-by":"object"}]},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of dibenzazepine compounds on Nav1.2 channels and neuronal network activity: A systematic comparison","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178147"}}